A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus Nephritis

NCT01085097 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

46

Enrollment

INDUSTRY

Sponsor class

Conditions

Lupus Nephritis

Interventions

DRUG: Laquinimod
DRUG: Mycophenolate Mofetil
DRUG: Prednisolone/Prednisone
DRUG: Placebo
DRUG: Methylprednisolone

Sponsor

Teva Branded Pharmaceutical Products R&D, Inc.